Associate Professor Polly Chen led the study, arguing that targeting DDX6 could strip cancer cells of their immune-friendly “cloak,” potentially redefining how RNA editing and immune regulation are approached in cancer therapy.

DDX6 works with the RNA-editing enzyme ADAR1 to dampen endogenous double-stranded RNA signals, reducing immune activation and making tumors less visible to immune surveillance.

By cooperating with ADAR1, DDX6 suppresses immune activation and may limit the effectiveness of immunotherapies by keeping tumors hidden from the immune system.

The team seeks to develop novel cancer immunotherapies or enhance existing ones by identifying DDX6 blockers and additional pathway components.

The research shows that certain RNA editing events can enhance dsRNA and promote immune activation, with DDX6 preventing these beneficial edits.

Targeting DDX6 could reactivate immune signaling, slow tumor progression, and potentially enhance the effectiveness of existing or future cancer immunotherapies.

Researchers are pursuing molecules that block DDX6 and aim to map other proteins in the same pathway to identify new targets for boosting anti-tumor immunity.

The findings, published in Science Immunology, challenge the idea that RNA editing generally weakens immune-stimulating RNA structures, showing that certain edits can strengthen dsRNA and activate immune responses.

A Science Immunology study from the Cancer Science Institute of Singapore identifies the RNA helicase DDX6 as a hidden switch that suppresses dsRNA sensing and helps cancer cells evade the immune system.

The Singapore study describes DDX6 as a mechanism by which cancer cells evade immune detection by dampening endogenous dsRNA sensing.

Overall, the work offers a new framework for understanding RNA editing in immune regulation and points toward a promising direction for developing more effective cancer treatments.

Laboratory data show that removing or inhibiting DDX6 restores immune signaling and slows tumor growth by making cancer cells more visible to the immune system.